Literature DB >> 20159112

Mutations in TSPAN12 cause autosomal-dominant familial exudative vitreoretinopathy.

James A Poulter1, Manir Ali, David F Gilmour, Aine Rice, Hiroyuki Kondo, Kenshi Hayashi, David A Mackey, Lisa S Kearns, Jonathan B Ruddle, Jamie E Craig, Eric A Pierce, Louise M Downey, Moin D Mohamed, Alexander F Markham, Chris F Inglehearn, Carmel Toomes.   

Abstract

Familial exudative vitreoretinopathy (FEVR) is an inherited blinding disorder of the retinal vascular system. Although mutations in three genes (LRP5, FZD4, and NDP) are known to cause FEVR, these account for only a fraction of FEVR cases. The proteins encoded by these FEVR genes form part of a signaling complex that activates the Norrin-beta-catenin signaling pathway. Recently, through a large-scale reverse genetic screen in mice, Junge and colleagues identified an additional member of this signaling complex, Tspan12. Here, we report that mutations in TSPAN12 also cause autosomal-dominant FEVR. We describe seven mutations identified in a cohort of 70 FEVR patients in whom we had already excluded the known FEVR genes. This study provides further evidence for the importance of the Norrin-beta-catenin signaling pathway in the development of the retinal vasculature and also indicates that more FEVR genes remain to be identified. Copyright (c) 2010 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159112      PMCID: PMC2820188          DOI: 10.1016/j.ajhg.2010.01.012

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Detecting polymorphisms and mutations in candidate genes.

Authors:  Julianne S Collins; Charles E Schwartz
Journal:  Am J Hum Genet       Date:  2002-11       Impact factor: 11.025

Review 2.  Functional domains in tetraspanin proteins.

Authors:  Christopher S Stipp; Tatiana V Kolesnikova; Martin E Hemler
Journal:  Trends Biochem Sci       Date:  2003-02       Impact factor: 13.807

3.  Multiple sequence alignment with the Clustal series of programs.

Authors:  Ramu Chenna; Hideaki Sugawara; Tadashi Koike; Rodrigo Lopez; Toby J Gibson; Desmond G Higgins; Julie D Thompson
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Progressive cerebellar, auditory, and esophageal dysfunction caused by targeted disruption of the frizzled-4 gene.

Authors:  Y Wang; D Huso; H Cahill; D Ryugo; J Nathans
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

5.  A new locus for autosomal dominant familial exudative vitreoretinopathy maps to chromosome 11p12-13.

Authors:  L M Downey; T J Keen; E Roberts; D C Mansfield; M Bamashmus; C F Inglehearn
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

6.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.

Authors:  Johane Robitaille; Marcia L E MacDonald; Ajamete Kaykas; Laird C Sheldahl; Jutta Zeisler; Marie-Pierre Dubé; Lin-Hua Zhang; Roshni R Singaraja; Duane L Guernsey; Binyou Zheng; Lee F Siebert; Ann Hoskin-Mott; Michael T Trese; Simon N Pimstone; Barkur S Shastry; Randall T Moon; Michael R Hayden; Y Paul Goldberg; Mark E Samuels
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

7.  TSPAN12 regulates retinal vascular development by promoting Norrin- but not Wnt-induced FZD4/beta-catenin signaling.

Authors:  Harald J Junge; Stacey Yang; Jeremy B Burton; Kim Paes; Xiao Shu; Dorothy M French; Mike Costa; Dennis S Rice; Weilan Ye
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

8.  Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity.

Authors:  H Kondo; H Hayashi; K Oshima; T Tahira; K Hayashi
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

9.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

Authors:  Carmel Toomes; Helen M Bottomley; Richard M Jackson; Katherine V Towns; Sheila Scott; David A Mackey; Jamie E Craig; Li Jiang; Zhenglin Yang; Richard Trembath; Geoffrey Woodruff; Cheryl Y Gregory-Evans; Kevin Gregory-Evans; Michael J Parker; Graeme C M Black; Louise M Downey; Kang Zhang; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025

10.  Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor.

Authors:  Masaki Kato; Millan S Patel; Regis Levasseur; Ivan Lobov; Benny H-J Chang; Donald A Glass; Christine Hartmann; Lan Li; Tae-Ho Hwang; Cory F Brayton; Richard A Lang; Gerard Karsenty; Lawrence Chan
Journal:  J Cell Biol       Date:  2002-04-15       Impact factor: 10.539

View more
  61 in total

Review 1.  Wnt Signaling in vascular eye diseases.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Shuo Huang; Jing Chen
Journal:  Prog Retin Eye Res       Date:  2018-12-01       Impact factor: 21.198

2.  Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits β-catenin degradation.

Authors:  Konstantin Knoblich; Hong-Xing Wang; Chandan Sharma; Anne L Fletcher; Shannon J Turley; Martin E Hemler
Journal:  Cell Mol Life Sci       Date:  2013-08-18       Impact factor: 9.261

Review 3.  The inner blood-retinal barrier: Cellular basis and development.

Authors:  Mónica Díaz-Coránguez; Carla Ramos; David A Antonetti
Journal:  Vision Res       Date:  2017-06-27       Impact factor: 1.886

4.  Macular Microvascular Findings in Familial Exudative Vitreoretinopathy on Optical Coherence Tomography Angiography.

Authors:  S Tammy Hsu; Avni P Finn; Xi Chen; Hoan T Ngo; Robert J House; Cynthia A Toth; Lejla Vajzovic
Journal:  Ophthalmic Surg Lasers Imaging Retina       Date:  2019-05-01       Impact factor: 1.300

Review 5.  The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease.

Authors:  Xin Ye; Yanshu Wang; Jeremy Nathans
Journal:  Trends Mol Med       Date:  2010-08-03       Impact factor: 11.951

6.  An essential role of the cysteine-rich domain of FZD4 in Norrin/Wnt signaling and familial exudative vitreoretinopathy.

Authors:  Kang Zhang; Yuko Harada; Xinran Wei; Dhananjay Shukla; Anand Rajendran; Khaled Tawansy; Matthew Bedell; Sharon Lim; Peter X Shaw; Xi He; Zhenglin Yang
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

Review 7.  Frizzled Receptors in Development and Disease.

Authors:  Yanshu Wang; Hao Chang; Amir Rattner; Jeremy Nathans
Journal:  Curr Top Dev Biol       Date:  2016-01-27       Impact factor: 4.897

8.  The TspanC8 subgroup of tetraspanins interacts with A disintegrin and metalloprotease 10 (ADAM10) and regulates its maturation and cell surface expression.

Authors:  Elizabeth J Haining; Jing Yang; Rebecca L Bailey; Kabir Khan; Richard Collier; Schickwann Tsai; Steve P Watson; Jon Frampton; Paloma Garcia; Michael G Tomlinson
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

9.  Pharmacologic Activation of Wnt Signaling by Lithium Normalizes Retinal Vasculature in a Murine Model of Familial Exudative Vitreoretinopathy.

Authors:  Zhongxiao Wang; Chi-Hsiu Liu; Ye Sun; Yan Gong; Tara L Favazza; Peyton C Morss; Nicholas J Saba; Thomas W Fredrick; Xi He; James D Akula; Jing Chen
Journal:  Am J Pathol       Date:  2016-08-12       Impact factor: 4.307

10.  ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature.

Authors:  Rob W J Collin; Konstantinos Nikopoulos; Margo Dona; Christian Gilissen; Alexander Hoischen; F Nienke Boonstra; James A Poulter; Hiroyuki Kondo; Wolfgang Berger; Carmel Toomes; Tomoko Tahira; Lucas R Mohn; Ellen A Blokland; Lisette Hetterschijt; Manir Ali; Johanne M Groothuismink; Lonneke Duijkers; Chris F Inglehearn; Lea Sollfrank; Tim M Strom; Eiichi Uchio; C Erik van Nouhuys; Hannie Kremer; Joris A Veltman; Erwin van Wijk; Frans P M Cremers
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.